Abstract
There is a causal relationship between cancer (including colorectal cancer),chronic systemic inflammation and persistent infections, and the presence of dysregulatedcirculating inflammatory markers. It is known that aberrant clot formation and coagulopathiesoccur in systemic inflammation. In colorectal cancer, there is a close link betweengut dysbiosis and an inflammatory profile. In this review, we present evidence ofthe connection between gut dysbiosis, the entry of bacteria into the internal environment,and the presence of their highly potent inflammagenic molecules, such aslipopolysaccharide and lipoteichoic acid, in circulation. These bacterial components mayact as one of the main drivers of the inflammatory process (including hypercoagulation)in colorectal cancer. We review literature that points to the role of these bacterial inflammagensand how they contribute to colorectal carcinogenesis. Insight into the factors thatpromote carcinogenesis is crucial to effectively prevent and screen for colorectal cancer.Early diagnosis of an activated coagulation system and the detection of bacterial componentsin circulation and also in the tumour microenvironment, could therefore be important,and may also, together with modulation of the gut microbiota, serve as potential therapeutictargets.
Keywords:Colorectal cancer, gut microbiome, bacterial inflammagens, inflammation, hypercoagulation, tumour development.
Current Medicinal Chemistry
Title:The Link Between Bacterial Inflammagens, Leaky Gut Syndrome andColorectal Cancer
Volume: 28Issue: 41
Author(s):Greta M de Waal*, Willem J.S. de Villiers and Etheresia Pretorius*
Affiliation:
- Department of Physiological Sciences, Stellenbosch University, Stellenbosch, Private Bag X1 Matieland,7602, South Africa
- Department of Physiological Sciences, Stellenbosch University, Stellenbosch, Private Bag X1 Matieland,7602, South Africa
Keywords:Colorectal cancer, gut microbiome, bacterial inflammagens, inflammation, hypercoagulation, tumour development.
Abstract: There is a causal relationship between cancer (including colorectal cancer),chronic systemic inflammation and persistent infections, and the presence of dysregulatedcirculating inflammatory markers. It is known that aberrant clot formation and coagulopathiesoccur in systemic inflammation. In colorectal cancer, there is a close link betweengut dysbiosis and an inflammatory profile. In this review, we present evidence ofthe connection between gut dysbiosis, the entry of bacteria into the internal environment,and the presence of their highly potent inflammagenic molecules, such aslipopolysaccharide and lipoteichoic acid, in circulation. These bacterial components mayact as one of the main drivers of the inflammatory process (including hypercoagulation)in colorectal cancer. We review literature that points to the role of these bacterial inflammagensand how they contribute to colorectal carcinogenesis. Insight into the factors thatpromote carcinogenesis is crucial to effectively prevent and screen for colorectal cancer.Early diagnosis of an activated coagulation system and the detection of bacterial componentsin circulation and also in the tumour microenvironment, could therefore be important,and may also, together with modulation of the gut microbiota, serve as potential therapeutictargets.
Export Options
About this article
Cite this article as:
de Waal M Greta *, de Villiers J.S. Willem and Pretorius Etheresia*, The Link Between Bacterial Inflammagens, Leaky Gut Syndrome andColorectal Cancer, Current Medicinal Chemistry 2021; 28 (41) .https://dx.doi.org/10.2174/0929867328666210219142737
DOI https://dx.doi.org/10.2174/0929867328666210219142737 | Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher | Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for manyyears. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium,tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. Thecontinuing interest in ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
- The J-shaped Association Between Alcohol Consumption and Breast Cancer: A Case-Control Study
Current Nutrition & Food ScienceOxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
Current Pharmaceutical DesignThe Role of Histone Demethylase GASC1 in Cancer and its Therapeutic Potential
Current Cancer Therapy Reviews Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Current Medicinal Chemistry Development of Cancer Vaccine Targeting WT1 Product which is Expressed in Various Kinds of Malignant Neoplasms
Medicinal Chemistry Reviews - Online (Discontinued) The Interaction of Dietary Fibres with the Colon
Current Nutrition & Food ScienceElectronic Noses in Medical Diagnostics
Current Medicinal ChemistryMicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug TargetsCucurbitacins as Anticancer Agents: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery Molecular Approaches to Cervical Cancer Therapy
Current Drug Discovery TechnologiesNovel Nanotechnology Approaches for Targeted Cancer Therapy
Recent Patents on NanomedicineDevelopment of Effective and Safe Analgesic and Anti-Inflammatory Drugs:Harnessing Natural Substances for Clinical Solutions
Recent Advances in Inflammation & Allergy Drug Discovery Histone Variant H2A.Z Can Serve as a New Target for Breast Cancer Therapy
Current Medicinal ChemistryEpigenetic Evaluation of N-(2-hydroxyphenyl)-2-Propylpentanamide, a Valproic Acid Aryl Derivative with Activity Against HeLa Cells
Current Molecular PharmacologyRemodeling of the Gut Microbiota in Colorectal Cancer and its Associationwith Obesity
Current Pharmaceutical Design Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Current Cancer Drug TargetsDevelopment of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line
Current Drug DeliveryExploring the Role of Phytochemicals as Potent Natural Photosensitizers in Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry
[8]ページ先頭